Geron Corporation (GERN) Presents New Data at the 67th American Society of Hematology 2025 Annual Meeting [Yahoo! Finance]
Geron Corporation (GERN)
Last geron corporation earnings: 3/12 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
geron.com/investors
Company Research
Source: Yahoo! Finance
that new data was presented at the 67th American Society of Hematology (ASH) 2025 Annual Meeting at Orlando, Florida, with the poster and oral presentations collectively adding to the evidence supporting RYTELO's potential across lower-risk myelodysplastic syndromes/neoplasms (LR-MDS) and myelofibrosis (MF). RYTELO (imetelstat) is Geron Corporation's (NASDAQ:GERN) first-in-class telomerase inhibitor. Management stated that the new data provides additional insights into the working of imetelstat and shows its potential long-term benefit as a differentiated treatment option for eligible patients with lower-risk MDS. In addition, the oral presentation from pooled analyses of the IMerge population shows that treatment-emergent cytopenias may reflect on-target effects linked to meaningful clinical outcomes, which include transfusion independence and hemoglobin increases in lower-risk MDS. Additional analyses in myelofibrosis and advanced MDS/AML also provide significant context for gaini
Show less
Read more
Impact Snapshot
Event Time:
GERN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GERN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GERN alerts
High impacting Geron Corporation news events
Weekly update
A roundup of the hottest topics
GERN
News
- Geron Corporation: Can Restructuring Bring The Stock Back To Life? I'm On The Sidelines [Seeking Alpha]Seeking Alpha
- Geron Corporation Announces Strategic Restructuring Plan to Position the Company for Long-Term Value Creation [Yahoo! Finance]Yahoo! Finance
- Geron Corporation Announces Strategic Restructuring Plan to Position the Company for Long-Term Value CreationGlobeNewswire
- Geron (NASDAQ:GERN) had its "neutral" rating reaffirmed by analysts at HC Wainwright.MarketBeat
- Geron (NASDAQ:GERN) had its "neutral" rating reaffirmed by analysts at UBS Group AG.MarketBeat
GERN
Earnings
- 11/5/25 - In-Line
GERN
Sec Filings
- 11/7/25 - Form 10-Q
- 11/5/25 - Form 8-K
- 10/20/25 - Form 3
- GERN's page on the SEC website